MR-387-B
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Enzyme inhibitors |
| Catalog number | BBF-03673 |
| CAS | |
| Molecular Weight | 488.58 |
| Molecular Formula | C25H36N4O6 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
MR-387-B is an AP-N inhibitor produced by the strain of Streptomyces neyagawaensis SL-387. It is used to inhibit AP-N activity in cells derived from porcine kidney microsomes, human fibrosarcoma HT-1080 and human myeloid leukemia K562.
- Specification
- Properties
- Price Product List
| IUPAC Name | 1-[1-[2-[(3-amino-2-hydroxy-4-phenylbutanoyl)amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid |
| Canonical SMILES | CC(C)C(C(=O)N1CCCC1C(=O)N2CCCC2C(=O)O)NC(=O)C(C(CC3=CC=CC=C3)N)O |
| InChI | InChI=1S/C25H36N4O6/c1-15(2)20(27-22(31)21(30)17(26)14-16-8-4-3-5-9-16)24(33)28-12-6-10-18(28)23(32)29-13-7-11-19(29)25(34)35/h3-5,8-9,15,17-21,30H,6-7,10-14,26H2,1-2H3,(H,27,31)(H,34,35) |
| InChI Key | ZLNGLBIUHZXFQA-UHFFFAOYSA-N |
| Appearance | White Powder |
| Antibiotic Activity Spectrum | neoplastics (Tumor) |
| Boiling Point | 839.2±65.0°C at 760 mmHg |
| Density | 1.3±0.1 g/cm3 |
| BBF-00703 | Carminomycin I | Inquiry |
| BBF-02800 | DB-2073 | Inquiry |
| BBF-04621 | Artemisinin | Inquiry |
| BBF-05827 | Spliceostatin A | Inquiry |
| BBF-01829 | Deoxynojirimycin | Inquiry |
| BBF-05734 | Irofulven | Inquiry |
Bio Calculators
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
